2023-04-01 2024-03-31 2024-03-31 Trading false The accounts were prepared in accordance with frs102 With an accountants report AbridgedAccounts This company is a private limited company 08453736 2024-03-31 08453736 2023-03-31 08453736 2022-03-31 08453736 2023-04-01 2024-03-31 08453736 2022-04-01 2023-03-31 08453736 uk-cd-pres:AllEntityOfficers 2023-04-01 2024-03-31 08453736 uk-cd-pres:AllEntityOfficers 2022-04-01 2023-03-31 08453736 uk-cd-pres:CompanySecretary1 2023-04-01 2024-03-31 08453736 uk-cd-pres:CompanySecretaryDirector1 2023-04-01 2024-03-31 08453736 uk-cd-pres:CompanySecretaryDirector1 2024-03-31 08453736 uk-cd-pres:Director1 2023-04-01 2024-03-31 08453736 uk-cd-pres:Director1 2024-03-31 08453736 uk-cd-pres:Director2 2023-04-01 2024-03-31 08453736 uk-cd-pres:Director2 2024-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2024-03-31 08453736 uk-cd-pres:AllPreferenceShares 2024-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2023-03-31 08453736 uk-cd-pres:AllPreferenceShares 2023-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2023-04-01 2024-03-31 08453736 uk-cd-pres:AllPreferenceShares 2023-04-01 2024-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2022-04-01 2023-03-31 08453736 uk-cd-pres:AllPreferenceShares 2022-04-01 2023-03-31 08453736 uk-cd-pres:RegisteredOffice 2023-04-01 2024-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2024-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 08453736 uk-cd-pres:EntityBankers 2023-04-01 2024-03-31 08453736 uk-cd-pres:EntityLawyersOrLegalAdvisers 2023-04-01 2024-03-31 08453736 uk-countries:UnitedKingdom 2023-04-01 2024-03-31 08453736 uk-countries:Europe 2023-04-01 2024-03-31 08453736 uk-countries:NorthAmerica 2023-04-01 2024-03-31 08453736 uk-countries:OtherCountriesRegions 2023-04-01 2024-03-31 08453736 uk-countries:UnitedKingdom 2022-04-01 2023-03-31 08453736 uk-countries:Europe 2022-04-01 2023-03-31 08453736 uk-countries:NorthAmerica 2022-04-01 2023-03-31 08453736 uk-countries:OtherCountriesRegions 2022-04-01 2023-03-31 08453736 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2023-04-01 2024-03-31 08453736 uk-gaap-pt:LeasedTangibleFixedAssets 2023-04-01 2024-03-31 08453736 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2022-04-01 2023-03-31 08453736 uk-gaap-pt:LeasedTangibleFixedAssets 2022-04-01 2023-03-31 08453736 uk-gaap-pt:OwnedAssets 2023-04-01 2024-03-31 08453736 uk-gaap-pt:LeasedAssets 2023-04-01 2024-03-31 08453736 uk-gaap-pt:OwnedAssets 2022-04-01 2023-03-31 08453736 uk-gaap-pt:LeasedAssets 2022-04-01 2023-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2024-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2023-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2023-04-01 2024-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2022-04-01 2023-03-31 08453736 uk-gaap-pt:NetGoodwill 2023-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2023-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2023-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2023-03-31 08453736 uk-gaap-pt:NetGoodwill 2023-04-01 2024-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2023-04-01 2024-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2023-04-01 2024-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2023-04-01 2024-03-31 08453736 uk-gaap-pt:NetGoodwill 2024-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2024-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2024-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2024-03-31 08453736 uk-gaap-pt:Buildings 2023-04-01 2024-03-31 08453736 uk-gaap-pt:Land 2023-04-01 2024-03-31 08453736 uk-gaap-pt:LandBuildings 2023-03-31 08453736 uk-gaap-pt:PlantMachinery 2023-03-31 08453736 uk-gaap-pt:FurnitureFittings 2023-03-31 08453736 uk-gaap-pt:FurnitureFittings 2023-03-31 08453736 uk-gaap-pt:OfficeEquipment 2023-03-31 08453736 uk-gaap-pt:Vehicles 2023-03-31 08453736 uk-gaap-pt:LandBuildings 2023-04-01 2024-03-31 08453736 uk-gaap-pt:PlantMachinery 2023-04-01 2024-03-31 08453736 uk-gaap-pt:FurnitureFittings 2023-04-01 2024-03-31 08453736 uk-gaap-pt:FurnitureFittings 2023-04-01 2024-03-31 08453736 uk-gaap-pt:OfficeEquipment 2023-04-01 2024-03-31 08453736 uk-gaap-pt:Vehicles 2023-04-01 2024-03-31 08453736 uk-gaap-pt:LandBuildings 2024-03-31 08453736 uk-gaap-pt:PlantMachinery 2024-03-31 08453736 uk-gaap-pt:FurnitureFittings 2024-03-31 08453736 uk-gaap-pt:OfficeEquipment 2024-03-31 08453736 uk-gaap-pt:Vehicles 2024-03-31 08453736 uk-gaap-ptx:AdministrativeExpenses 2023-04-01 2024-03-31 08453736 uk-gaap-ptx:AdministrativeExpenses 2022-04-01 2023-03-31 08453736 uk-gaap-ptx:CostSales 2023-04-01 2024-03-31 08453736 uk-gaap-ptx:CostSales 2022-04-01 2023-03-31 08453736 uk-gaap-ptx:DistributionCosts 2023-04-01 2024-03-31 08453736 uk-gaap-ptx:DistributionCosts 2022-04-01 2023-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2023-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2023-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2023-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2023-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments 2024-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments 2023-03-31 08453736 uk-gaap-pt:WithinOneYear 2024-03-31 08453736 uk-gaap-pt:BetweenOneTwoYears 2024-03-31 08453736 uk-gaap-pt:BetweenTwoFiveYears 2024-03-31 08453736 uk-gaap-pt:MoreThanFiveYears 2024-03-31 08453736 uk-gaap-pt:AfterOneYear 2024-03-31 08453736 uk-gaap-pt:WithinOneYear 2023-03-31 08453736 uk-gaap-pt:BetweenOneTwoYears 2023-03-31 08453736 uk-gaap-pt:BetweenTwoFiveYears 2023-03-31 08453736 uk-gaap-pt:MoreThanFiveYears 2023-03-31 08453736 uk-gaap-pt:AfterOneYear 2023-03-31 08453736 uk-gaap-pt:ShareCapital 2024-03-31 08453736 uk-gaap-pt:SharePremium 2024-03-31 08453736 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2024-03-31 08453736 uk-gaap-pt:RevaluationReserve 2024-03-31 08453736 uk-gaap-pt:OtherReservesSubtotal 2024-03-31 08453736 uk-gaap-pt:ShareCapital 2023-03-31 08453736 uk-gaap-pt:SharePremium 2023-03-31 08453736 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2023-03-31 08453736 uk-gaap-pt:RevaluationReserve 2023-03-31 08453736 uk-gaap-pt:OtherReservesSubtotal 2023-03-31 08453736 1 2023-04-01 2024-03-31 08453736 2 2023-04-01 2024-03-31 08453736 uk-cd-pres:FRS102 2023-04-01 2024-03-31 08453736 uk-cd-pres:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 08453736 uk-cd-pres:FullAccounts 2023-04-01 2024-03-31 08453736 uk-cd-pres:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure
 
 
 
 
 
 
 
C. B. Therapy Solutions Limited
 
 
Company Registration Number
08453736
 
 
Report of the Directors and
Abridged Unaudited Financial Statements
 
 
Period of accounts
 
Start date 01/04/2023
 
End date 31/03/2024
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 1
C. B. Therapy Solutions Limited
 
Contents of the Financial Statements
for the Period Ended 31 March 2024
 
 
Page
Company Information 3
 
Report of the Accountants 4
 
Abridged Balance Sheet 5 - 6
 
Notes to the Financial Statements 7 - 10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2
C. B. Therapy Solutions Limited
Company Information
for the Period Ended 31 March 2024
 
Directors Mrs Christine Vanessa Board
Mr Keith Robert Board
 
Company secretary Mr Keith Robert Board
 
Registered office 1 Stockwell Avenue
Mangotsfield
Bristol
BS16 9DR
 
Company Registration Number 08453736
 
Accountants Name Christopher John Edwards & Co. Limited
Address 17 Vayre Close
Chipping Sodbury
Bristol
BS37 6NT
South Gloucestershire
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 3
C. B. Therapy Solutions Limited
 
Accountants' Report
for the Period Ended 31 March 2024
 
Independent accountants' report
 
Report to the directors on the preparation of the unaudited statutory accounts of the company for theperiod ended 31 March 2024. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of the company for the period ended 31 March 2024 as set out on pages 3 to 10 which comprise of the Balance Sheet and the related notes from the companys accounting records and from information and explanations you have given us. This report is made solely to the Board of Directors of the company, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the
accounts of the company and state those matters that we have agreed to state to the Board of Directors
of the company, as a body, in this report. To the fullest extent permitted by law, we do not accept or
assume responsibility to anyone other than the company and its Board of Directors as a body for our
work or for this report.
 
It is your duty to ensure the company has kept adequate accounting records and to prepare statutory
accounts that give a true and fair view of the assets, liabilities, financial position and profit/(loss) of
the company. You consider the company is exempt from the statutory audit requirement for the
period.
We have not been instructed to carry out an audit of the financial statements. For this reason, we
have not verified the accuracy or completeness of the accounting records or information and
explanations you have given to us and we do not, therefore, express any opinion on the financial
statements.
 
 
 
 
 
 
 
Christopher John Edwards & Co. Limited
17 Vayre Close
Chipping Sodbury
Bristol
BS37 6NT
South Gloucestershire
 
Date 2024-12-26
Page 4
C. B. Therapy Solutions Limited
Balance Sheet
for the Period Ended 31 March 2024
Company registration number 08453736
2024 2,023
Notes £ £
Fixed assets
Tangible fixed assets 2 214 286
_______ _______
Total fixed assets 214 286
Current assets
Stocks 3 200 150
Debtors 4 55
Cash at bank and in hand 5,382 10,799
_______ _______
Total current assets/(liabilities) 5,637 10,949
Creditors
Creditors - amounts falling
due within one year 5 2,311 3,074
_______ _______
Net current assets 3,326 7,875
_______ _______
Total assets less current liabilities 3,540 8,161
_______ _______
Net assets/(liabilities) 3,540 8,161
Capital and reserves
Called up share capital 6 2 2
Profit and loss account 7 3,538 8,159
____ ____
Total shareholders funds 3,540 8,161
 
 
 
 
 
 
 
 
 
 
 
 
Page 5
C. B. Therapy Solutions Limited
 
Balance Sheet
for the Period Ended 31 March 2024
 
 
 
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The option not to file the profit and loss account has been taken.
 
For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
 
The financial statements were approved by the Board of Directors on 2024-12-27
 
SIGNED ON BEHALF OF THE BOARD BY
 
 
 
 
 
 
 
Name Mrs Christine Vanessa Board
Status Director
 
The notes form part of these financial statements
Average number of employees during period 1
 
 
 
 
 
 
 
Page 6
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2024
1. Accounting policies
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with the small companies regime.
Tangible fixed assets Depreciation
Depreciation is provided, after taking account of any grants receivable, at the following annual rates in order to write off each asset over its estimated useful life.
Office equipment 0
Stocks
Stocks and work-in-progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost includes all direct expenditure and an appropriate proportion of fixed and variable overheads.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Pension costs
The company operates a defined contribution pension scheme for employees. The annual contributionspayable are charged to the profit and loss account.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 7
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2024
2. Tangible fixed assets
Office Total
equipment
Cost £ £
At 1 April 2023 1,334 1,334
____ ____
At 31 March 2024 1,334 1,334
Depreciation
At 1 April 2023 1,048 1,048
Charge for year 72 72
____ ____
At 31 March 2024 1,120 1,120
Net book value
At 31 March 2024 214 214
At 31 March 2023 286 286
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 8
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2024
3. Stocks 2024 2,023
Finished goods 200 150
Total 200 150
4. Debtors 2024 2,023
Trade debtors 55
__ _
Total 55 0
5. Creditors amounts falling due within one year 2024 2,023
Corporation tax 2,011 2,774
Accruals and deferred income 300 300
____ ____
Total 2,311 3,074
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 9
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2024
6. Share capital 2024 2,023
Allotted, called up and paid £ £
Ordinary shares of £ 1.00 each 2 2
_ _
Total 2 2
7. Reserves/Retained profit
Retained profit reconciliation £
Reserves at 1 April 2023 8,159
Profit/(Loss) for year 8,502
Dividends paid 13,123
____
Retained Profit/(Loss) at 31 March 2024 3,538
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 10